Mostrando 10 resultados de: 12
Filtros aplicados
Área de conocimiento
Cáncer(10)
Bioquímica(3)
Descubrimiento de fármacos(2)
Farmacología(2)
Medicamento(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(12)
ODS 10: Reducción de las desigualdades(11)
ODS 12: Producción y consumo responsables(3)
ODS 17: Alianzas para lograr los objetivos(3)
ODS 5: Igualdad de género(3)
Origen
scopus(12)
"Getting from here to there"-mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer
ReviewAbstract: Despite the clinical regression that typifies the initial response of advanced prostate cancer to goPalabras claves:androgen receptor, Androgens, Steroid metabolismAutores:McPhaul M., Richard J. Auchus, Sharifi N.Fuentes:scopus3β-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer
ArticleAbstract: Prostate cancer usually responds to androgen deprivation therapy, although the response in metastatiPalabras claves:Autores:Evaul K., Li R., Papari-Zareei M., Richard J. Auchus, Sharifi N.Fuentes:scopusAndrostenedione is the preferred androgen source in hormone refractory prostate cancer Letter
OtherAbstract:Palabras claves:Autores:Richard J. Auchus, Sharifi N.Fuentes:scopusConversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
ArticleAbstract: Prostate cancer resistance to castration occurs because tumours acquire the metabolic capability ofPalabras claves:Autores:Alyamani M., Bishop A., Bunch D., Dreicer R., Garcia J., Li Z., Liu J., Richard J. Auchus, Sharifi N., Upadhyay S.K.Fuentes:scopusAbiraterone inhibits 3β-hydroxysteroid dehydrogenase: A rationale for increasing drug exposure in castration-resistant prostate cancer
ArticleAbstract: Purpose: Treatment with abiraterone (abi) acetate prolongs survival in castration-resistant prostatePalabras claves:Autores:Chang K.H., Evaul K., Li R., Liu J., Richard J. Auchus, Sharifi N., Sharma K.K., Yoshimoto J.A.Fuentes:scopusDihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
ArticleAbstract: In the majority of cases, advanced prostate cancer responds initially to androgen deprivation therapPalabras claves:5-alpha-androstanedione, Abiraterone acetate, Hormonal therapy, Hormone resistance, Tumor metabolismAutores:Chang K.H., Li R., Papari-Zareei M., Richard J. Auchus, Sharifi N., Watumull L., Zhao Y.Fuentes:scopusHSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer
ArticleAbstract: BACKGROUND. A common germline variant in HSD3B1(1245A>C) encodes for a hyperactive 3β-hydroxysteroidPalabras claves:Autores:Almassi N., Alyamani M., Berk M.P., Chien C., Emamekhoo H., Figg W.D., Garcia J., Grivas P.D., Hu B., Hwang T.H., Koshkin V.S., Mendiratta P., Park S., Peer C.J., Richard J. Auchus, Rini B., Sharifi N., Taylor J., Tyler A., Upadhyay S.K.Fuentes:scopusSteroid biosynthesis and prostate cancer
ReviewAbstract: The pathways of androgen biosynthesis in human beings have been studied for decades, and the major pPalabras claves:Abiraterone acetate, androgen receptor, Dihydrotestosterone, Prostate cancer, steroidogenesis, TestosteroneAutores:Richard J. Auchus, Sharifi N.Fuentes:scopusMolecular pathways: Inhibiting steroid biosynthesis in prostate cancer
ReviewAbstract: A significant proportion of castration-resistant prostate cancers (CRPC) remains driven by ligand acPalabras claves:Autores:Attard G., Ferraldeschi R., Richard J. Auchus, Sharifi N.Fuentes:scopusSex Hormones and Prostate Cancer
ReviewAbstract: The prostate is an androgen-dependent organ that develops only in male mammals. Prostate cancer is tPalabras claves:prostate cancer, androgen, steroidogenesis, abiraterone acetate, adrenalAutores:Richard J. Auchus, Sharifi N.Fuentes:scopus